The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Initiatives

POCTRN

Developing Point-of-Care Technologies with Clinical Applications

POCTRN


The goal of the Point Of Care Technology Research Network is to develop technologies with clinical applications using a network model that enhances complementary strengths and builds multidisciplinary partnerships.

To achieve this, each POCTRN Center performs or facilitates five core functions:

  • Conducts in-house clinical testing of prototype point-of-care devices
  • Collaborates with physical, biochemical and computational scientists, and engineers on exploratory technology development projects
  • Completes clinical needs assessments in areas anticipated to advance the field of point-of-care testing and disseminates this information to the technology development community
  • Provides training to technology developers on clinical issues related to the development of point-of-care devices
  • Provides an adequate administrative structure to ensure that the large complex Center achieves its goals

Learn more >

Our Lasting Impact

As an early pioneer in managing translational research, Cimit has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.

We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.